Osiris Therapeutics (OSIR) Misses Q2 EPS by 3c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Osiris Therapeutics (OSIR) Misses Q2 EPS by 3c

Osiris Therapeutics Announces Second Quarter 2015 Financial Results

August 5, 2015 8:01 AM EDT

COLUMBIA, Md.--(BUSINESS WIRE)-- Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading cellular regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine, announced today its financial results for the second quarter of 2015.

Second Quarter Highlights and Developments

Increased product revenue for the quarter to $23.7 million - a 78%... More